drugset / Trial / NCT01142336
Effects of Simvastatin on Biomarkers
Phase 4
Completed
49 enrolled
University of Washington
Seattle Institute for Biomedical and Clinical Research · collabVA Puget Sound Health Care System · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
A year-long randomized, double-blind, placebo-controlled trial of simvastatin to see if it produces beneficial changes in cerebral spinal fluid proteins associated with Alzheimer's disease.
Timeline
- Start
- 2010-06
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | — |